Wird geladen...
What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer?
Assessment of the clinical benefit of cancer treatments can be highly subjective, influenced by both perspective and context. Such assessments are required in regulatory and policy decision-making, but consistency between jurisdictions is often lacking. Clear and consistent standards for determining...
Gespeichert in:
| Veröffentlicht in: | Curr Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Multimed Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6476454/ https://ncbi.nlm.nih.gov/pubmed/31043834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4753 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|